Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli Berg

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Scandinavian Journal of Primary Health Care|September 14, 2007
Examination of final-year medical students in general practiceIvar J Aaraas, Knut Holtedahl, Tor Anvik, et al.
Biochimica Et Biophysica Acta|July 22, 2014
PAC-1 and isatin derivatives are weak matrix metalloproteinase inhibitorsStian Sjøli, Ann Iren Solli, Oyvind Akselsen, et al.
Plos One|August 4, 2018
The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteasesIngebrigt Sylte, Rangita Dawadi, Nabin Malla, et al.
BMC Cancer|May 21, 2017
Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasionSynnove Norvoll Magnussen, Elin Hadler-Olsen, Daniela Elena Costea, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Scandinavian Journal of Primary Health Care|September 14, 2007
Examination of final-year medical students in general practiceIvar J Aaraas, Knut Holtedahl, Tor Anvik, et al.
Biochimica Et Biophysica Acta|July 22, 2014
PAC-1 and isatin derivatives are weak matrix metalloproteinase inhibitorsStian Sjøli, Ann Iren Solli, Oyvind Akselsen, et al.
Plos One|August 4, 2018
The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteasesIngebrigt Sylte, Rangita Dawadi, Nabin Malla, et al.
BMC Cancer|May 21, 2017
Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasionSynnove Norvoll Magnussen, Elin Hadler-Olsen, Daniela Elena Costea, et al.
Pageof 2